| Literature DB >> 33632102 |
Jiayi Wu1, Daiqiang Liu1, Jiayan Li1, Jia Sun1, Yujie Huang1, Shuang Zhang1, Shaojie Gao1, Wei Mei2.
Abstract
Great progress has been made in specifically identifying the central neural circuits (CNCs) of the core body temperature (Tcore), sleep-wakefulness states (SWs), and general anesthesia states (GAs), mainly utilizing optogenetic or chemogenetic manipulations. We summarize the neuronal populations and neural pathways of these three CNCs, which gives evidence for the orchestration within these three CNCs, and the integrative regulation of these three CNCs by different environmental light signals. We also outline some transient receptor potential (TRP) channels that function in the CNCs-Tcore and are modulated by some general anesthetics, which makes TRP channels possible targets for addressing the general-anestheticsinduced- hypothermia (GAIH). We suggest this review will provide new orientations for further consummating these CNCs and elucidating the central mechanisms of GAIH. Copyright© Bentham Science Publishers; For any queries, please email at epub@benthamscience.net.Entities:
Keywords: Central neural circuits; TRP channels; body temperature regulation; chemogenetics; general anesthesia; intrinsically photosensitive retinal ganglion cells; optogenetics; sleep-wakefulness states
Mesh:
Year: 2022 PMID: 33632102 PMCID: PMC9199556 DOI: 10.2174/1570159X19666210225152728
Source DB: PubMed Journal: Curr Neuropharmacol ISSN: 1570-159X Impact factor: 7.708
Fig. (3)A model of the central thermoregulatory circuits controlled by environmental light signals. The light signal as well as the circadian photoentrainment is transmitted to the SCN and POA through the retinohypothalamic tract and then the downstream subparaventricular zone (SPZ), DMH and PVH. The POA→DMH→RPa/VLM pathway is canonical, functioning together with other thermoregulatory circuits, including the ARH-, DMH-, DRN-, osmo-sodium-related and other possible pathways.
Fig. (4)A model of the central neural circuits of sleep-wakefulness states controlled by environmental light signals. The light-related pathway also regulates the LH and LC, both of which are wakefulness-promoting. The LH sends innervations to extensive locations, including the basal forebrain (BF), TRN, PVT, TMN, VTA, DRN, laterodorsal tegmental area (LDT)/ pedunculopontine tegmental area (PPT), PBN and LC. The arousal-promoting system, includes the LC, PBN, LDT/PPT, DRN, VTA, TMN, BF, PVT, NAc and BNST, while the NREM sleep-promoting pathways involves the inhibition of the wakefulness-promoting pathways by the POA, the inhibition of the cortex by the basal forebrain (BF), and the inhibition of the LH by VTA. The LHb is also NREM sleep-promoting, while the related pathway(s) is not clear (indicated by dotted line). The DRN can be wakefulness-promoting when hungry while sleep-permissive during satiety. Additionally, the latest finding suggests that the VLPOVglut2 neurons are wakefulness-promoting whilst the MnPOVgat neurons are NREM sleep-promoting. The DRN, PAG and LC participate in the REM sleep-regulating pathways to mutually regulate the muscle paralysis of REM sleep by directly inhibiting the excitatory sublaterodorsal nucleus (SLD)→VMM pathway or indirectly inhibit the excitatory LDT/PPT→SLD pathway, and the PAG receives inhibitory projections from the SLD. The LDT/PPT→BF pathway may help drive the typical fast EEG activity of REM sleep. And the BLA/CeA→medial prefrontal cortex (mPFC) pathway may also regulate REM sleep. (Adapted from [8]).
Central locations or pathways regulating core body temperature or(and) sleep-wakefulness states.
|
|
|
|
|
|
|
|
| Refs. | ||||||
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
|
|
|
|
|
|
|
|
|
| ||||||
| POA | TRPM2 | hM3Dq | Inactive | ↑ | ↓ | ↑ | ↓ | N/A | N/A | N/A | N/A | [ | ||
| POA | TRPM2 | hM4Di | Inactive | ↓ | ↑ | ND | ND | N/A | N/A | N/A | N/A | [ | ||
| POA | Vglut2 | hM3Dq | Inactive | ↑ | ↓ | N/A | N/A | N/A | N/A | N/A | N/A | [ | ||
| POA | Vgat | hM3Dq | Inactive | ↑ | ND | N/A | N/A | N/A | N/A | N/A | N/A | [ | ||
| POA | Ptgds | hM3Dq | Inactive | ↑ | ↓ | N/A | N/A | N/A | N/A | N/A | N/A | [ | ||
| POA | Ptgds | hM3Dq | Active | ↑ | ND | N/A | N/A | N/A | N/A | N/A | N/A | [ | ||
| POA | Ptgds | hM4Di | Inactive | ↓ | ↑ | N/A | N/A | N/A | N/A | N/A | N/A | [ | ||
| POA | Ptgds | hM4Di | Active | ↓ | ND | N/A | N/A | N/A | N/A | N/A | N/A | [ | ||
| vLPO | Vgat | ChR | No | ↑ | ↓ | N/A | N/A | ↓ | N/A | N/A | N/A | [ | ||
| vLPO | Vgat | hGtACR1 | No | ↓ | ↑ | N/A | N/A | ↑ | N/A | N/A | N/A | [ | ||
| vLPO | Vglut2 | ChR | No | ↑ | ↓ | N/A | N/A | ↓ | N/A | N/A | N/A | [ | ||
| vLPO | Vglut2 | hM3Dq | No | ↑ | ↓ | N/A | N/A | N/A | N/A | N/A | N/A | [ | ||
| VLPO | Gal | ChR | Tamb=22°C, active | ↑ | ND | N/A | N/A | N/A | ↑ | ND | N/A | N/A | N/A | [ |
| VLPO | Gal | ArCH | Tamb=22°C, active and inactive | ↓ | ND | N/A | N/A | N/A | ↓ | ND | N/A | N/A | N/A | [ |
| VLPO | Gal | hM3Dq | Tamb=22°C, active and inactive | ↑ | ↓ | N/A | N/A | N/A | ↑ | ↓ | N/A | N/A | N/A | [ |
| VLPO | Gal | hM3Dq | Tamb=29°C, activea | ↑ | ↓ | N/A | N/A | N/A | ↑ | ↓↓ | N/A | N/A | N/A | [ |
| VLPO | Gal | hM3Dq | Tamb=36°C, activea | ↑ | ND | N/A | N/A | N/A | ↑ | ↓ | N/A | N/A | N/A | [ |
| VLPO | Gal | hM3Dq | Tamb=29°C, inactivea | ↑ | ↓ | N/A | N/A | N/A | N/A | ↑^ | N/A | N/A | N/A | [ |
| VLPO | Gal | hM3Dq | Tamb=22°C, inactive, cage exchangeb | ↑ | SIH ↓ | N/A | N/A | N/A | ↑ | ND | SIW ↓ | N/A | N/A | [ |
| LPO | Gal | hM3Dq | active | ↑ | ↓ | N/A | N/A | N/A | ↑ | ND | ↓ | N/A | N/A | [ |
| MPO | Vgat | ChR | no | ↑ | ND | N/A | N/A | ND | N/A | N/A | N/A | [ | ||
| MnPO, VMPO | LepRb | hM3Dq | inactive | ↑ | ↓ | N/A | N/A | ↓ | N/A | N/A | postural | [ | ||
| MnPO, VMPO | Vglut2 | hM3Dq | inactive | ↑ | ↓ | N/A | N/A | N/A | N/A | N/A | N/A | [ | ||
| MnPO, VMPO | Vgat | hM3Dq | inactive | ↑ | ND | N/A | N/A | N/A | N/A | N/A | N/A | [ | ||
| MnPO, VMPO | PACAP | SSFO | no | ↑ | ↓ | ↑ | ↓ | N/A | N/A | N/A | cold seeking↑, | [ | ||
| MnPO, VMPO | BDNF | SSFO | no | ↑ | ↓ | ↑ | ↓ | N/A | N/A | N/A | cold seeking↑, | [ | ||
| MnPOe | Vglut2 | ChR | Tamb=21°C, active and inactive | ↑ | ↓↓ | ↑ | N/A | N/A | ↓ | ND | ↑ | N/A | HR↓↓, drinking in | [ |
| MnPO | Vglut2 | ChR | Tamb=31°C, active and inactivea | ↑ | ↓ | ↑ | N/A | N/A | N/A | N/A | HR↓ | [ | ||
| MnPO, MPO | Nos1 | hM3Dq | Tamb=22°C, active | ↑ | ↓ | N/A | N/A | N/A | ↑ | N/A | ↓ | N/A | N/A | [ |
| MnPO, MPO | Vgat | hM3Dq | Tamb=22°C, active | ↑ | ND | N/A | N/A | N/A | ↑ | N/A | ↓ | N/A | N/A | [ |
| AVPe/MPA | QRFP | hM3Dq | Tamb=22°C | ↑ | ↓ (>48h) | N/A | ↓ (>48h) | hibernation-like immobility | A hibernation-like state with EEG amplitude↓ | VO2↓, HR↓, RR↓ | [ | |||
| AVPe/MPA | QRFP | hM4Di | Tamb=22°C | ↓ | N/A | N/A | N/A | N/A | N/A | N/A | N/A | [ | ||
| AVPe/MPA | QRFP | SSFO | Tamb=22°C | ↑ | ↓(~30min) | ↑(~30min) | ↓(~30min) | N/A | N/A | N/A | N/A | [ | ||
| POA→DMH | vLPOVgat | ChR | no | ↑ | ↓ | N/A | N/A | ↓ | N/A | N/A | N/A | [ | ||
| POA→DMH | POAPACAP | ChR | no | ↑ | ↓ | ND | ↓ | N/A | N/A | N/A | cold | [ | ||
| AVPe/MPA→DMH | AVPe/MPA Q | SSFO | Tamb=22°C | ↑ | ↓ | ↑ | ↓ | N/A | N/A | N/A | N/A | [ | ||
| AVPe/MPA→RPa | AVPe/MPA Q | SSFO | Tamb=22°C | ↑ | ↓ | ↑ | ↓ (subtle) | N/A | N/A | N/A | N/A | [ | ||
| DMH | ChAT | ChR | no | ↑ | ↓ | N/A | ↓ | N/A | N/A | N/A | N/A | [ | ||
| DMH | ChAT | ArCH | no | ↓ | ↑ | N/A | ↑ | N/A | N/A | N/A | N/A | [ | ||
| DMH | LepRb | hM3Dq | no | ↑ | ↑ | N/A | ↑ | ↑ | N/A | N/A | N/A | [ | ||
| DMH | Vglut2 | ChR | no | ↑ | ↑ | N/A | ↑ | N/A | N/A | N/A | N/A | [ | ||
| DMH | Vglut2 | hM3Dq | no | ↑ | ↑ | N/A | ↑ | N/A | N/A | N/A | N/A | [ | ||
| DMH | Vglut2 | hM3Dq | no | ↑ | ↑ | N/A | N/A | ↑ | N/A | N/A | N/A | [ | ||
| DMH | Vglut2 | hGtACR1 | no | ↓ | ↓ | N/A | N/A | ↓ | N/A | N/A | N/A | [ | ||
| DHA | Vglut2 | hGlyR | no | ↓ | ↓ | N/A | N/A | ND | N/A | N/A | N/A | [ | ||
| DHA | Vglut2 | hGlyR | cage exchangeb | ↓ | SIH ↓ | N/A | N/A | SIL ND | N/A | N/A | N/A | [ | ||
| DHA | Vglut2 | hM3Dq | no | ↑ | ↑ | ↑ | ↑ | ↑ | N/A | N/A | N/A | [ | ||
| DHA | Vglut2 | hM3Dq | cage exchangeb | ↑ | SIH ND | ↓ | ↑ | SIL ND | N/A | N/A | N/A | [ | ||
| DMH | Vgat | ChR | no | ↑ | ↑ | N/A | N/A | ↑ | N/A | N/A | N/A | [ | ||
| DMH | Vgat | hM3Dq | no | ↑ | ↑ | N/A | N/A | ↑ | N/A | N/A | N/A | [ | ||
| DMH | Vgat | hGtACR1 | no | ↓ | ↓ | N/A | N/A | ↓ | N/A | N/A | N/A | [ | ||
| DMH | Brs3 | hM3Dq | Tamb=22°C | ↑ | ↑ | N/A | N/A | ND | N/A | ND | TEE↑, BG↑ | [ | ||
| DMH | Brs3 | hM4Di | Tamb=22°C | ↓ | ↓ | N/A | N/A | ND | N/A | N/A | TEE↓ | [ | ||
| DMH | Brs3 | hM4Di | LPSc | ↓ | LIH ↓ | N/A | N/A | LIL ND | N/A | N/A | N/A | [ | ||
| DMH | Brs3 | hM4Di | cage exchangeb | ↓ | SIH ↓ | N/A | N/A | SIL ND | N/A | N/A | N/A | [ | ||
| DMH | Brs3 | hM4Di | Tamb=34°Ca | ↓ | ND | N/A | N/A | ND | N/A | N/A | N/A | [ | ||
| DMH | non- | ChR | Tamb=22°C | ↑ | ↑↑ | N/A | ↑ | ↑ | N/A | N/A | N/A | [ | ||
| DMH | Brs3 | ChR | Tamb=22°C | ↑ | ↑ | N/A | ↑ | ND | N/A | N/A | HR↑, MAP↑ | [ | ||
| DMH | non-Brs3 | ChR | Tamb=22°C | ↑ | ↑ | N/A | ↑ | ↑ | N/A | N/A | N/A | [ | ||
| DMH→RPa | DMHBrs3 | ChR | Tamb=22°C | ↑ | ↑ | N/A | N/A | ND | N/A | N/A | N/A | [ | ||
| DMH→rMR | non- | ChR | inactive | ↑ | ND | N/A | ↑ | N/A | N/A | N/A | HR↑, MAP↑ | [ | ||
| DMH→PAG | non- | hM3Dq | inactive | ↑ | ↑ | ↑ | N/A | ↑ | N/A | N/A | N/A | [ | ||
| DHA→RPa | DHAVglut2 | ArCH | no | ↓ | ↓ | N/A | N/A | N/A | N/A | N/A | N/A | [ | ||
| DHA→RPa | DHAVglut2 | ArCH | cage exchangeb | ↓ | SIH ↓ | N/A | N/A | N/A | N/A | N/A | N/A | [ | ||
| PVH | Brs3 | hM3Dq | no | ↑ | ND | N/A | N/A | ND | N/A | ↓ | TEE ND, BG ND | [ | ||
| PVH | Brs3 | hM4Di | inactive | ↓ | ND | N/A | N/A | ND | N/A | ↑ | N/A | [ | ||
| LH | Vglut2 | hM3Dq | no | ↑ | N/A | N/A | ↑ | N/A | N/A | N/A | N/A | [ | ||
| LH | MCH | hM3Dq | active and inactive | ↑ | ND | N/A | N/A | ND | ND | ↑ | ↓* | N/A | N/A | [ |
| LH | MCH | DTR | active and inactive | ablation | ND (inactive), ↑ (active) | N/A | N/A | ND (inactive), ↑ (active) | alteration of the diurnal distributions of REM and wakefulness (inactive) | ↓ | weight↓ | [ | ||
| LH | MCH | hM3Dq | inactive | ↑ | ND | N/A | N/A | ND | ND | ↑ | ND | N/A | N/A | [ |
| LH | Vglut2-KO MCH | hM3Dq | inactive | ↑ | ND | N/A | N/A | ND | ND | ↑ | ND | N/A | N/A | [ |
| LH | Nts | ChR | inactive | ↑ | ↑ | N/A | N/A | ND | NREM-wake but not REM-wake transitions | N/A | EMG↑ | [ | ||
| LH | Nts | hM3Dq | inactive | ↑ | ↑ | N/A | N/A | ↑ | a potential NREM rebound | a REM sleep rebound | Wakefulness for 4-6h | N/A | N/A | [ |
| LH | Nts | hM3Dq | active | ↑ | ↑↑ | N/A | N/A | ↑↑ | ND | ND | ND | N/A | N/A | [ |
| LH | Nts | hM4Di | active and inactive | ↓ | ND | N/A | N/A | ND | ND | ND | ND | N/A | N/A | [ |
| LH | Nts | hM4Di | inactive, cage changeb | ↓ | SIH ↓ | N/A | N/A | SIL ↓ | ↑ | ↑ | SIW ↓ | N/A | N/A | [ |
| LH | Nts | hM4Di | active, acute fastingd | ↓ | FIH ↓ | N/A | N/A | FIL ↑ | ↓ | ND | FIW ↑ | N/A | N/A | [ |
| LH | QRFP | hM3Dq | Tamb=22°C | ↑ | N/A | N/A | N/A | N/A | N/A | N/A | N/A | [ | ||
| ARH | Rip-Cre | hM3Dq | no | ↑ | ↑ | N/A | ↑ | N/A | N/A | ND | VO2↑, subcutaneous flank temperature ND | [ | ||
| ARH | Vgat KO | hM3Dq | no | ↑ | ↑ | N/A | ND | N/A | N/A | ND | VO2 ND | [ | ||
| ARH | Rip-Cre + Vgat KO | hM3Dq | no | ↑ | ↑ | N/A | ND | N/A | N/A | ND | VO2 ND | [ | ||
| ARH | Kiss1 | hM3Dq | active, female | ↑ | ↓ | ↑ | N/A | ↓ | N/A | N/A | N/A | [ | ||
| ARH | Kiss1 | hM3Dq | active, male | ↑ | ↓ | ↑ | N/A | N/A | N/A | N/A | N/A | [ | ||
| ARH | Kiss1 | ChR | active, female | ↑ | N/A | ↑ | N/A | N/A | N/A | N/A | N/A | [ | ||
| ARH | Kiss1 | ChR | active, male | ↑ | N/A | ↑ | N/A | N/A | N/A | N/A | N/A | [ | ||
| ARH | Kiss1 | hM3Dq | active, female, ovariectomy | ↑ | N/A | ↑ (more sensitive) | N/A | N/A | N/A | N/A | N/A | [ | ||
| ARH | Kiss1 | hM3Dq | active, female, NKBR antagonist into the POA | ↑ | N/A | ↓ | N/A | N/A | N/A | N/A | N/A | [ | ||
| ARH→POA | ARHKiss1 | ChR | active, female | ↑ | ↓ | ↑ | N/A | ↓ | N/A | N/A | N/A | [ | ||
| ARH→PVH | ARHRip-Cre | ChR | no (in vitro) | ↑ | N/A | N/A | N/A | IPSCs | [ | |||||
| ARH→PVH | ARHAgRP | ChR | no (in vitro) | ↑ | N/A | N/A | N/A | No IPSCs | [ | |||||
| NTS→RPa | NTSVgat | ChR | no (in vitro) | ↑ | N/A | N/A | N/A | IPSCs | [ | |||||
| DRN | Vgat | hM3Dq | inactive | ↑ | ↓ | ND | ↓ | ↓ | N/A | N/A | TEE↓ | [ | ||
| DRN | Vgat | hM3Dq | Inactive+ ISO (1-1.25%) | ↑ | ↓ | ND | ↓ | - | N/A | N/A | N/A | [ | ||
| DRN | Vgat | hM4Di | inactive | ↓ | ↑ | ND | ND | ↑ | N/A | N/A | TEE↑ | [ | ||
| DRN→RPa | DRNVgat | ChR | inactive | ↑ | ↓ | N/A | ↓ | N/A | N/A | ND | N/A | [ | ||
| DRN→BNST | DRNVgat | ChR | inactive | ↑ | ↓ | N/A | ↓ | N/A | N/A | ↑ | N/A | [ | ||
| DRN→DMH | DRNVgat | ChR | inactive | ↑ | ↓ | N/A | ↓ | N/A | N/A | ↑ | N/A | [ | ||
| DRN→MPO | DRNVgat | ChR | inactive | ↑ | ↓ | N/A | ↓ | N/A | N/A | ND | N/A | [ | ||
| DRN→BNST | DRNVgat | hM4Di | inactive | ↓ | ↑(transiently) | N/A | N/A | N/A | N/A | N/A | N/A | [ | ||
| DRN→DMH | DRNVgat | hM4Di | inactive | ↓ | ↑(transiently) | N/A | N/A | N/A | N/A | N/A | N/A | [ | ||
| DRN | SERT | hM3Dq | active and inactive | ↑ | ND | N/A | N/A | ↓* | ↑ | ↑ | ↓ | N/A | anxiolysis | [ |
| IRt/PCRt | Gad2 | hM3Dq | no | ↑ | ↓ | N/A | ↓ | N/A | N/A | N/A | HR↓ | [ | ||
| BLA | Glutamatergic | NpHR | footshock stress | ↓ | SIH ND | N/A | N/A | N/A | ND | ↑ | N/A | N/A | N/A | [ |
| ipRGCs | Brn3b | hM3Dq | active | ↑ | ↓ | N/A | N/A | N/A | N/A | N/A | N/A | [ | ||
Abbreviations: POA, the preoptic area; vLPO, the ventral part of the lateral preoptic nucleus; VLPO, the ventrolateral preoptic nucleus; LPO, the lateral preoptic area; MPO/MPA, the medial preoptic area; MnPO, the median preoptic nucleus; VMPO, the ventromedial preoptic nucleus; AVPe, the anteroventral periventricular nucleus; DMH, the dorsomedial hypothalamus; dDMH, the dorsal part of the dorsomedial hypothalamus; DHA, the dorsal hypothalamic area; RPa, the raphe pallidus; rRPa, the rostral raphe pallidus; rMR, the rostral medullary raphe area; PAG, the periaqueductal gray; PVH, the paraventricular nucleus of the hypothalamus; LH, the lateral hypothalamus; ARH, the arcuate nucleus of the hypothalamus; NTS, the nucleus of the solitary tract; DRN, the dorsal raphe nucleus; BNST, the bed nucleus of the stria terminalis; IRt/PCRt, the intermediate and parvicellular reticular nuclei; BLA, the basolateral nucleus of the amygdala; ipRGCs, the intrinsically photosensitive retinal ganglion cells; Ptgds, the gene that encodes lipocalin-type prostaglandin-D synthase; Gal, galanin; LepRb, leptin receptors; PACAP, pituitary adenylate cyclase-activating polypeptide; BDNF, brain-derived neurotrophic factor; Nos1, nitric oxide synthase 1; QRFP, pyroglutamylated RFamide peptide; Q, QRFP neurons; Brs3, Bombesin-like receptor 3; MCH, melanin-concentrating hormone; Nts, neurotensin; Rip-Cre, the rat insulin-2 promoter-Cre recombinase; Kiss1, kisspeptin/ neurokinin B; NKBR, neurokinin B receptor; ISO, isoflurane; SERT, the serotonin transporter; Brn3b, a transcription factor expressed in the M1 subtype of ipRGCs;
N/A, not assessed; ND, no difference; BAT, brown adipose tissue; NREM, non-rapid eye movement sleep; REM, rapid eye movement sleep; Tamb, ambient temperature; active/inactive, during the animals’ active/inactive cycles; HR, heart rate; VO2, oxygen consumption; RR, respiratory rate; TEE, total energy expenditure; BG, blood glucose; MAP, mean arterial pressure; EMG, electromyography; IPSCs, inhibitory postsynaptic currents.
Remarks:
#: for this column, “no” means under normal ambient temperature (about 22°C) with the experimental time (during whether the animals’ active or inactive cycles) unspecified; the normal ambient temperature is not specified unless the study involves different ambient temperature;
^: ↓ for 4h, then ↑ for the next 12h↓ until fully recovered;
*: slightly, no statistical difference;
a: these groups are compared to the control group (under the same ambient temperature but without optogenetic or chemogenetic manipulations), respectively;
b: these groups were compared to the control group (cage exchange but without optogenetic or chemogenetic manipulations), respectively, and the outcome was defined as whether the stress-induced hyperthermia (SIH), stress-induced locomotion (SIL) or stress-induced wakefulness (SIW) was changed;
c: this group was compared to the control group (LPS administration but without chemogenetic manipulation), and the outcome was defined as whether LPS-induced hyperthermia (LIH) or LPS-induced locomotion (LIL) was changed;
d: this group was compared to the control group (fasting but without chemogenetic manipulation), and the outcome was defined as whether fasting-induced hyperthermia (FIH), fasting-induced locomotion (FIL) or fasting-induced wakefulness (FIW) was changed;
e: for this study, there was a weak correlation between the hypothermic mice and the drinking-increasing mice, while the wakefulness-promoting mice showed no correlation to the hypothermic mice; the increase of drinking was more during active cycles.
Central locations or pathways regulating general anesthesia states or(and) sleep-wakefulness states.
|
|
|
|
|
|
|
|
|
|
| ||||||||||||||||||
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Anesthetics |
|
|
|
|
|
|
|
|
|
| |||||||||||||||||
|
|
|
|
|
|
|
|
|
|
|
|
| ||||||||||||||||
| MnPO (M) | Vgat | hM3Dq | inactive | 37-38°C | ↑ | ISO (1.5% OR 1.2%) | ND | ND | N/A | N/A | N/A | N/A | wake-like episodes (1.2%) | ↑ | ↓ | ↑ | N/A | ↓ | ↓ | N/A | N/A | ND | ↓ | N/A | N/A | Tc ND | [ |
| MnPO (M) | Vglut2 | hM3Dq | inactive | 37-38°C | ↑ | ISO (1.5% OR 1.2%) | ND | ND | N/A | N/A | N/A | N/A | wake-like episodes (1.2%) | ↑* | N/A | N/A | N/A | ↓ | N/A | N/A | N/A | ↑* | N/A | N/A | N/A | Tc ↓ | [ |
| VLPO (M) | Vgat | hM3Dq | inactive | 37-38°C | ↑ | ISO (1.5% OR 1.2%) | ND | ND | N/A | N/A | N/A | N/A | N/A | sleep-wakefulness states ND | N/A | [ | |||||||||||
| VLPO (M) | Vglut2 | hM3Dq | inactive | 37-38°C | ↑ | ISO (1.5% OR 1.2%) | ND | ND | N/A | N/A | N/A | N/A | N/A | ↓ | N/A | N/A | N/A | ↓ | N/A | N/A | N/A | ↑ | N/A | N/A | N/A | N/A | [ |
| SON (M)a | AANs | hM3Dq | active | N/A | ↑ | N/A | ↑ | ND | ↑ | N/A | ND | N/A | N/A | N/A | ↓ | N/A | N/A | N/A | N/A | [ | |||||||
| SON (M)a | AANs | hM3Dq | active | N/A | ↑ | N/A | ↑ | N/A | N/A | N/A | ND | N/A | N/A | N/A | ↓ | N/A | N/A | N/A | N/A | [ | |||||||
| SON (M)a | AANs | GFP (control) | active | N/A | ND | N/A | ↓ | N/A | N/A | N/A | ND | N/A | N/A | N/A | ↑ | N/A | N/A | N/A | N/A | [ | |||||||
| SON (M)a | AANs | ChR | active | N/A | ↑ | ISO (1.0%) | ND (induction time) | ↑ (fully awake time) | N/A | N/A | N/A | N/A | duration time ↑ | ↑(long-lasting) | N/A | N/A | δ↑ | ND | N/A | N/A | N/A | ↓ | N/A | N/A | N/A | N/A | [ |
| SON (M)a | AANs | DTR | whole day | N/A | ablation (chronic) | N/A | ↓ | ND | ↓ | δ↓ | ↓ | ↓ | ND | θ↓ | ↓ | N/A | N/A | N/A | N/A | [ | |||||||
| SON (M)a | AANs | eArch3.0 | active | N/A | ↓ | ISO (1.0%) | ND (induction time) | ↓ (fully awake time) | N/A | N/A | N/A | N/A | duration time ↓ | N/A | N/A | [ | |||||||||||
| LH (M) | orexin | hM3Dq | N/A | 35–37°C | ↑ | ISO (2.0%) | N/A | ↓ | N/A | N/A | N/A | β↓ (2.0%); δ↓, α↑, β↑ (ISO off) | EMG↑ (0.5%), pain tolerance↑ | N/A | N/A | [ | |||||||||||
| LH→TRN (M)b | LHGABA | ChETA | N/A | N/A | ↑ | ISO (0-1.2%) (burst-suppression) | no LORR (2 of 4 animals) | emergence (2 of 4 animals) | N/A | N/A | ↓ | N/A | burst duration (s)↑ | NREM-wake but not REM-wake transitions | N/A | [ | |||||||||||
| ISO (0-1.2%) (iso-electric) | ND | ND | N/A | N/A | N/A | N/A | burst duration (s) ND | ||||||||||||||||||||
| LH→LC (M) | LHGABA | ChETA | N/A | N/A | ↑ | N/A | NREM-wake and REM-wake transitions | N/A | [ | ||||||||||||||||||
| LH→PVT (M) | LHGABA | ChETA | N/A | N/A | ↑ | N/A | NREM-wake but not REM-wake transitions | N/A | [ | ||||||||||||||||||
| LH→VTA (R) | LHorexin | ChR | inactive | 35–37°C | ↑ | ISO (1.4%) | N/A | ↓ | N/A | N/A | ↓ | δ↓, α↑, β↑, γ↑ (0.8%) | behavioral arousal | N/A | N/A | [ | |||||||||||
| LH→VTA (R) | LHorexin | NpHR | inactive | 35–37°C | ↓ | ISO (1.4%) | N/A | ↑ | N/A | N/A | ND | θ↓, β↓ (0.8%) | no behavioral arousal | N/A | N/A | [ | |||||||||||
| LHb (M) | Grm2-Cre | hM3Dq | active | N/A | ↑ | N/A | ND | N/A | N/A | N/A | N/A | N/A | N/A | N/A | N/A | N/A | N/A | N/A | locomotion↓ | [ | |||||||
| LHb (M) | Grm2-Cre | GFP (control) | active | N/A | ND | PRO (7 mg/kg, i.v.) | N/A | N/A | N/A | N/A | N/A | δ and frequencies range from >10Hz to extending γ↑ | locomotion↓ | N/A | N/A | [ | |||||||||||
| LHb (M) | Grm2-Cre | TeLC | active | N/A | neurotransmission blocked | PRO (7 mg/kg, i.v.) | ↑ | N/A | ↑ | N/A | N/A | δ and higher frequencies↑ (slightly) | attenuation of the locomotion↓ | N/A | N/A | [ | |||||||||||
| LHb (M) | Grm2-Cre | TeLC | active or inactive | N/A | neurotransmission blocked | N/A | ↓ | ↑ | N/A | δ↓ | ND | ND | N/A | REM-wake transitions↑ | ↓ | ↑ (particularly when inactive) | N/A | N/A | N/A | [ | |||||||
| LHb (M) | Grm2-Cre | TeLC+ dual orexin-R antagonist | active | N/A | neurotransmission blocked+ orexinergic inhibition | N/A | ↑ | N/A | N/A | N/A | ND | N/A | N/A | N/A | ↓ | N/A | N/A | N/A | N/A | [ | |||||||
| PVT (M)c | Glutamatergic | hM4Di | active | N/A | ↓ | N/A | ↑ | ↑ | ND | N/A | ↑ | ↑ | ND | N/A | ↓ | ↑ | ↓ | δ (2-4Hz) ↑; micr0-arousal number↑ | N/A | [ | |||||||
| PVT (M)c | Glutamatergic | hM4Di | inactive | N/A | ↓ | N/A | sleep-wakefulness states ND | N/A | [ | ||||||||||||||||||
| PVT (M)c | Glutamatergic | DTA | whole day | N/A | ablation (chronic) | N/A | ↑ | ↑ | ND | α↓ | ND | ND | ND | N/A | ↓ | ↑ | ↓ | high↑, low θ↑, α↓; micro-arousal number↑ | sleep-wakefulness states ND (inactive) | [ | |||||||
| PVT (M)c | Glutamatergic | IBO | whole day | N/A | lesion (acute) | N/A | ↑ | ↑ | ND | N/A | ↑ | ND | ND | N/A | ↓ | ↑ | ↓ | high δ↑, α↓; micro-arousal number↑ | locomotion and exploratory activities↓ (active); sleep-wakefulness states ND (inactive) | [ | |||||||
| PVT (M)c | Glutamatergic | ChR | inactive | N/A | ↑ | ISO | N/A | ↓ | N/A | N/A | ↓ | δ↑, θ↓ | burst duration (s)↑ | NREM-wake and REM-wake transitions | N/A | [ | |||||||||||
| PVT→NAc (M)c | PVTGlu | ChR | inactive | N/A | ↑ | N/A | NREM-wake and REM-wake transitions | N/A | [ | ||||||||||||||||||
| PVT→NAc (M)c | PVTGlu | hM4Di | active | N/A | ↓ | N/A | ↑ | ↑ | ND | N/A | ND | ND | ND | N/A | ↓ | ↑ | ↓ | N/A | N/A | [ | |||||||
| LH→PVT (M) | LHorexin | hM4Di | active | N/A | ↓ | N/A | ↑ | ↑ | N/A | N/A | ND | ND | N/A | N/A | ↓ | N/A | N/A | N/A | N/A | [ | |||||||
| LH→PVT (M) | LHorexin | ChR | inactive | N/A | ↑ | N/A | sleep-wake transition | N/A | [ | ||||||||||||||||||
| LH (M) | orexin | hM3Dq | N/A | N/A | ↑ | N/A | N/A | N/A | N/A | N/A | N/A | N/A | N/A | N/A | ↑# | N/A | N/A | N/A | N/A | [ | |||||||
| TRN (M)d | Vgat | ChR | N/A | N/A | ↑ | ISO | N/A | N/A | N/A | N/A | N/A | broadband (0.5-50Hz) ↓ | the cortex is shifted into a deeper state | ↑ | N/A | N/A | δ↑, spindle ↓ | ND | N/A | N/A | N/A | ↓ | N/A | N/A | δ↑ | EMG↓, locomotion↓ | [ |
| TRN (M) | Vgat | eNpHR | stimulation time was shuffled | N/A | ↓ | N/A | N/A | N/A | N/A | δ↓ | N/A | N/A | N/A | N/A | N/A | N/A | N/A | δ ND | locomotion ND | [ | |||||||
| VTA (M)e | DAT | YFP (control) | N/A | normothermia | ND | ISO | N/A | N/A | N/A | N/A | N/A | ND | no behavioral arousal | N/A | N/A | [ | |||||||||||
| VTA (M)e | DAT | ChR | N/A | normothermia | ↑ | ISO | N/A | N/A | N/A | N/A | N/A | <5Hz↓, 6-17Hz↓ | behavioral arousal, propensity for righting↑ | N/A | N/A | [ | |||||||||||
| VTA (M)e | DAT | ChR+ D1-R antagonist | N/A | normothermia | ↑ | ISO | N/A | N/A | N/A | N/A | N/A | 6-17Hz↓ | no behavioral arousal | N/A | N/A | [ | |||||||||||
| VTA (M) | Vgat | ChR | N/A | N/A | ↑ | ISO (0.8%, or 1.0%) | N/A | N/A | N/A | N/A | ↑ (1.0%) | δ↑, β↓, γ↓ (0.8%) | N/A | N/A | N/A | [ | |||||||||||
| VTA (M) | Vgat | eNpHR | N/A | N/A | ↓ | ISO (0.8%, or 1.0%) | N/A | N/A | N/A | N/A | ↓ (1.0%) | δ↓, θ↓, α↓, γ↑ (0.8%) | N/A | N/A | N/A | [ | |||||||||||
| VTA (M) | Vgat | hM3Dq | N/A | N/A | ↑ | ISO (1.4%) | ↓ | ↑ | ↓ | ↓ | N/A | N/A | N/A | N/A | N/A | [ | |||||||||||
| VTA (M) | Vgat | hM4Di | N/A | N/A | ↓ | ISO (1.4%) | ↑ | ↓ | ↑ | ↑ | N/A | N/A | N/A | N/A | N/A | [ | |||||||||||
| VTA→LH (M) | VTAVgat | ChR | N/A | N/A | ↑ | ISO (0.8%, or 1.0%) | N/A | N/A | N/A | N/A | ↑ (1.0%) | δ↑, β ND, γ↓ (0.8%) | N/A | N/A | N/A | [ | |||||||||||
| VTA→LH (M) | VTAVgat | eNpHR | N/A | N/A | ↓ | ISO (0.8%, or 1.0%) | N/A | N/A | N/A | N/A | ↓ (1.0%) | δ↓, θ ND, α↓, γ↑ (0.8%) | N/A | N/A | N/A | [ | |||||||||||
| VTA→LH (M) | VTAVgat | ChR | N/A | N/A | ↑ | ISO (1.4%) | ↓ | ↑ | N/A | N/A | N/A | N/A | N/A | N/A | N/A | [ | |||||||||||
| VTA→LH (M) | VTAVgat | eNpHR | N/A | N/A | ↓ | ISO (1.4%) | ↑ | ND | N/A | N/A | N/A | N/A | N/A | N/A | N/A | [ | |||||||||||
| PBN (M) | Vglut2 | hM3Dq | N/A | N/A | ↑ | SEVO (2.0%) | ↑ | ↓ | ↑ | N/A | N/A | N/A | N/A | N/A | N/A | [ | |||||||||||
| PBN (M) | Vglut2 | hM4Di | N/A | N/A | ↓ | SEVO (2.0%) | ND | ↑ | ↓ | N/A | N/A | N/A | N/A | N/A | N/A | [ | |||||||||||
| PBN (M) | Vglut2 | ChR | N/A | N/A | ↑ | SEVO (2.0%) | N/A | N/A | N/A | N/A | N/A | low δ↓, θ↑ | N/A | N/A | N/A | [ | |||||||||||
| LC (R) | PRSx8 | hM3Dq | active | 36.0-37.5°C | ↑ | ISO (2.0%) | ↑ | ↓ | N/A | N/A | ↓ | δ↓, θ↑ | Locomotion ND | N/A | N/A | [ | |||||||||||
| LC→TRN (M) | LCTH | hM3Dq | active | 36.0-37.5°C | ↑ | PRO (90 mg/kg, i.p.) | ND | ↑ | ND | ↓ | N/A | δ↑ | N/A | N/A | N/A | [ | |||||||||||
| LC→TRN (M) | LCTH | hM3Dq+ | active | 36.0-37.5°C | ↑ | PRO (90 mg/kg, i.p.) | N/A | ↓ | N/A | N/A | N/A | reversal of the δ↑ | N/A | N/A | N/A | [ | |||||||||||
Abbreviations: SON, the supraoptic nucleus; TRN, thalamic reticular nucleus; LC, the locus coeruleus; PVT, the paraventricular thalamus; VTA, the ventral tegmental area; LHb, the lateral habenula; NAc, the nucleus accumbens; PBN, the parabrachial nucleus;
AANs, anesthesia-activated neurons; Grm2-Cre, the metabotropic glutamate receptor 2-Cre recombinase; TeLC, tetanus toxin light chain; DTA, diphtheria toxin A; IBO, ibotenic acid; DAT, dopamine transporter; PRSx8, the synthetic dopamine β hydroxylase (DBH) promoter; TH, tyrosine hydroxylase; prazosin, the selective a1-adrenoceptor blocker;
M, mice; R, rats; ND, no difference; N/A, not assessed; active/inactive, during active/inactive cycles; ISO, isoflurane; PRO, propofol; SEVO, sevoflurane; the percentage in bracket is referred to the concentration of the volatile anesthetic; Tc, core body temperature.
Remarks:
*: no statistical difference;
#: with or without chemogenetic inhibition of the PVT;
a: for this study, the NREM is referred to SWS (slow-wave sleep); the time of Induction was determined by the onset of strong slow-wave power in EEG and minimal muscle activity in EMG; the time point of Fully Awake was determined by diminished slow-wave power and re-appearance of movement continuously for at least 1 min; the total Duration of unconscious time was calculated by the time point of Fully Awake minus the time point of Induction;
b: for this study, the optogenetic stimulation was given once stable burst-suppression mode was recorded or during iso-electric activity;
c: for this study, the cell type of the PVT was non-specific, but primarily deemed to be glutamatergic; ISO was 2% for induction and 1.5% after the induction
d: for this study, ISO was 1.5% for induction, 0.6-1% for maintaining lightly anesthetized range;
e: for this study, ISO was 2.5% for 20 min and then 0.8-0.9% for maintenance; behavior arousal was assessed by arousal score.